This review summarizes the current evaluation and management of gestational trophoblastic
disease, including evacuation of hydatidiform moles, surveillance after evacuation of …

Significant improvements in treatment and the understanding of gestational trophoblastic
neoplasia have occurred in the last 15 years. These diseases are almost always curable …

Gestational trophoblastic disease (GTD) comprises a spectrum of disorders from the pre-
malignant conditions of complete (CHM) and partial (PHM) hydatidiform moles through to …

Objective The objective of this study was to provide a consensus review on gestational
trophoblastic disease diagnosis and management from the combined International Society …

Gestational trophoblastic diseases (GTD) are a group of pregnancy-related disorders
representing rare human tumours. They encompass premalignant disorders including …

Background Patients with gestational trophoblastic neoplasia who have an International
Federation of Gynaecology and Obstetrics (FIGO) risk score of 5 or 6 usually receive non …

Gestational trophoblastic disease (GTD) is a group of interrelated tumors that arise from
abnormal fertilization events and include both benign conditions (complete hydatidiform …

Checkpoint inhibitors are likely to play an increasing role in the future management of GTN
management. Further refinement of prognostic factors to identify those most at risk of GTN …

Gestational trophoblastic disease (GTD) includes a group of interrelated diseases arising
from the placenta with varying tendencies for local invasion and metastases [1],[2]. GTD …

Gestational trophoblastic disease describes a variety of pregnancy-related diseases
including the premalignant conditions of a partial and complete hydatidiform mole and the …